Xvivo Perfusion AB (publ) (XVIPY)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	570	1,392	1,032	524	909	1,098
Market Cap Growth	-61.99%	34.85%	97.06%	-42.36%	-17.26%	126.84%
Enterprise Value	554	1,353	976	494	878	1,025
Last Close Price	4.70	10.67	6.24	4.62	-	-
PE Ratio	179.76	89.46	113.04	296.26	1007.78	-
PS Ratio	6.61	18.73	17.37	13.15	31.80	50.14
PB Ratio	2.57	7.14	5.34	3.82	6.39	8.94
P/TBV Ratio	3.76	10.81	7.84	6.86	10.06	11.59
P/FCF Ratio	-	379.77	3172.09	564.50	-	-
P/OCF Ratio	70.52	138.41	224.23	195.98	-	-
EV/Sales Ratio	6.53	18.21	16.42	12.40	30.71	46.80
EV/EBITDA Ratio	38.49	135.06	515.41	387.15	-	-
EV/EBIT Ratio	78.05	167.53	1818.08	1156.32	-	-
EV/FCF Ratio	-216.61	369.29	2998.27	532.54	-	-
Debt / Equity Ratio	0.06	0.02	0.02	0.01	0.00	0.01
Debt / EBITDA Ratio	0.90	0.28	1.06	0.51	-	-
Debt / FCF Ratio	-	0.84	9.61	1.03	-	-
Asset Turnover	0.35	0.36	0.30	0.25	0.19	0.20
Inventory Turnover	0.86	1.12	1.23	1.29	1.02	0.97
Quick Ratio	3.27	3.14	4.94	2.60	4.43	5.51
Current Ratio	5.41	4.58	6.15	3.47	5.24	6.41
Return on Equity (ROE)	1.43%	8.39%	5.44%	1.36%	0.71%	-5.51%
Return on Assets (ROA)	1.83%	2.43%	0.17%	0.17%	-0.87%	-3.09%
Return on Capital (ROIC)	1.97%	2.68%	0.20%	0.20%	-1.02%	-3.45%
Return on Capital Employed (ROCE)	3.00%	4.00%	0.30%	0.30%	-	-
Earnings Yield	0.56%	1.12%	0.89%	0.34%	0.10%	-0.48%
FCF Yield	-0.45%	0.26%	0.03%	0.18%	-0.27%	-0.17%
Buyback Yield / Dilution	-1.25%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.